Corvus Pharmaceuticals Inc’s recently made public that its insider Jones William Benton acquired Company’s shares for reported $34624.0 on May 06 ’24. In the deal valued at $1.73 per share,20,000 shares were bought. As a result of this transaction, Jones William Benton now holds 153,773 shares worth roughly $0.51 million.
Then, MILLER RICHARD A MD bought 577,634 shares, generating $1,000,000 in total proceeds. Upon buying the shares at $1.73, the President and CEO now owns 577,634 shares.
H.C. Wainwright initiated its Corvus Pharmaceuticals Inc [CRVS] rating to a Buy in a research note published on January 02, 2025; the price target was $11. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in mid August with a ‘”an Outperform”‘ rating. Cantor Fitzgerald started covering the stock on May 27, 2021. It rated CRVS as “an Overweight”.
Price Performance Review of CRVS
On Tuesday, Corvus Pharmaceuticals Inc [NASDAQ:CRVS] saw its stock jump 3.42% to $3.33. Over the last five days, the stock has gained 9.90%. Corvus Pharmaceuticals Inc shares have fallen nearly -37.76% since the year began. Nevertheless, the stocks have risen 136.17% over the past one year. While a 52-week high of $10.00 was reached on 01/06/25, a 52-week low of $1.39 was recorded on 04/09/25. SMA at 50 days reached $3.92, while 200 days put it at $5.15.
Levels Of Support And Resistance For CRVS Stock
The 24-hour chart illustrates a support level at 3.24, which if violated will result in even more drops to 3.14. On the upside, there is a resistance level at 3.39. A further resistance level may holdings at 3.44. The Relative Strength Index (RSI) on the 14-day chart is 45.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 4.24%. Stochastics %K at 85.61% indicates the stock is a selling.
How much short interest is there in Corvus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Corvus Pharmaceuticals Inc stocks on 2025-03-31, dropping by -0.43 million shares to a total of 4.92 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 5.35 million shares. There was a decline of -8.78%, which implies that there is a negative sentiment for the stock.
